Literature DB >> 15161925

Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1).

Philip J Jensik1, Jodi I Huggenvik, Michael W Collard.   

Abstract

Deformed epidermal autoregulatory factor-1 (DEAF-1) is a DNA-binding protein required for embryonic development and linked to clinical depression and suicidal behavior in humans. Although primarily nuclear, cytoplasmic localization of DEAF-1 has been observed, and this suggests the presence of a nuclear export signal (NES). Using a series of fluorescent fusion proteins, an NES with a novel spacing of leucines (LXLX(6)LLX(5)LX(2)L) was identified near the COOH-terminal MYND domain at amino acids 454-476. The NES was leptomycin B-sensitive and mutation of the leucine residues decreased or eliminated nuclear export activity. In vitro pull downs and an in vivo fluorescent protein interaction assay identified a DEAF-1/DEAF-1 protein interaction domain within the NES region. DNA binding had been previously mapped to a positively charged surface patch in the novel DNA binding fold called the "SAND" domain. A second protein-protein interaction domain was identified at amino acids 243-306 that contains the DNA-binding SAND domain and also an adjacent zinc binding motif and a monopartite nuclear localization signal (NLS). Deletion of these adjacent sequences or mutation of the conserved cysteines or histidine in the zinc binding motif not only inhibits protein interaction but also eliminates DNA binding, demonstrating that DEAF-1 protein-protein interaction is required for DNA recognition. The identification of an NES and NLS provides a basis for the control of DEAF-1 subcellular localization and function, whereas the requirement of protein-protein interaction by the SAND domain appears to be unique among this class of transcription factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161925     DOI: 10.1074/jbc.M400946200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.

Authors:  Rebecca Fuhlbrigge; Linda Yip
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype.

Authors:  Li Chen; Philip J Jensik; Joseph T Alaimo; Magdalena Walkiewicz; Seth Berger; Elizabeth Roeder; Eissa A Faqeih; Jonathan A Bernstein; Ann C M Smith; Sureni V Mullegama; David W Saffen; Sarah H Elsea
Journal:  Hum Mutat       Date:  2017-09-23       Impact factor: 4.878

3.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Authors:  F Kyle Satterstrom; Jack A Kosmicki; Jiebiao Wang; Michael S Breen; Silvia De Rubeis; Joon-Yong An; Minshi Peng; Ryan Collins; Jakob Grove; Lambertus Klei; Christine Stevens; Jennifer Reichert; Maureen S Mulhern; Mykyta Artomov; Sherif Gerges; Brooke Sheppard; Xinyi Xu; Aparna Bhaduri; Utku Norman; Harrison Brand; Grace Schwartz; Rachel Nguyen; Elizabeth E Guerrero; Caroline Dias; Catalina Betancur; Edwin H Cook; Louise Gallagher; Michael Gill; James S Sutcliffe; Audrey Thurm; Michael E Zwick; Anders D Børglum; Matthew W State; A Ercument Cicek; Michael E Talkowski; David J Cutler; Bernie Devlin; Stephan J Sanders; Kathryn Roeder; Mark J Daly; Joseph D Buxbaum
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

4.  Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.

Authors:  Philip J Jensik; Lydia A Arbogast
Journal:  Mol Cell Endocrinol       Date:  2014-11-04       Impact factor: 4.102

5.  Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes.

Authors:  Linda Yip; Leon Su; Deqiao Sheng; Pearl Chang; Mark Atkinson; Margaret Czesak; Paul R Albert; Ai-Ris Collier; Shannon J Turley; C Garrison Fathman; Rémi J Creusot
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

6.  Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.

Authors:  Anneke T Vulto-van Silfhout; Shivakumar Rajamanickam; Philip J Jensik; Sarah Vergult; Nina de Rocker; Kathryn J Newhall; Ramya Raghavan; Sara N Reardon; Kelsey Jarrett; Tara McIntyre; Joseph Bulinski; Stacy L Ownby; Jodi I Huggenvik; G Stanley McKnight; Gregory M Rose; Xiang Cai; Andy Willaert; Christiane Zweier; Sabine Endele; Joep de Ligt; Bregje W M van Bon; Dorien Lugtenberg; Petra F de Vries; Joris A Veltman; Hans van Bokhoven; Han G Brunner; Anita Rauch; Arjan P M de Brouwer; Gemma L Carvill; Alexander Hoischen; Heather C Mefford; Evan E Eichler; Lisenka E L M Vissers; Björn Menten; Michael W Collard; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2014-04-10       Impact factor: 11.025

7.  Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.

Authors:  Margaret Czesak; Sylvie Lemonde; Erica A Peterson; Anastasia Rogaeva; Paul R Albert
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

8.  Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4.

Authors:  Liza Cubeddu; Soumya Joseph; Derek J Richard; Jacqueline M Matthews
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

9.  Deformed epidermal autoregulatory factor-1 (DEAF1) interacts with the Ku70 subunit of the DNA-dependent protein kinase complex.

Authors:  Philip J Jensik; Jodi I Huggenvik; Michael W Collard
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  DEAF1 is a Pellino1-interacting protein required for interferon production by Sendai virus and double-stranded RNA.

Authors:  Alban Ordureau; Karine Enesa; Sambit Nanda; Brice Le Francois; Mark Peggie; Alan Prescott; Paul R Albert; Philip Cohen
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.